Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017

  • ID: 4394484
  • Report
  • 119 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Boston Scientific Corp
  • Cerevast Therapeutics Inc
  • Integer Holdings Corp
  • Medtronic plc
  • Newronika s.r.l.
  • University of Illinois
  • MORE
Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017" provides an overview of Deep Brain Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Deep Brain Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Deep Brain Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Deep Brain Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Boston Scientific Corp
  • Cerevast Therapeutics Inc
  • Integer Holdings Corp
  • Medtronic plc
  • Newronika s.r.l.
  • University of Illinois
  • MORE
1 Table of Contents
2 Introduction
2.1 Deep Brain Stimulators Overview
3 Products under Development
3.1 Deep Brain Stimulators - Pipeline Products by Stage of Development
3.2 Deep Brain Stimulators - Pipeline Products by Territory
3.3 Deep Brain Stimulators - Pipeline Products by Regulatory Path
3.4 Deep Brain Stimulators - Pipeline Products by Estimated Approval Date
3.5 Deep Brain Stimulators - Ongoing Clinical Trials
4 Deep Brain Stimulators - Pipeline Products under Development by Companies
4.1 Deep Brain Stimulators Companies - Pipeline Products by Stage of Development
4.2 Deep Brain Stimulators - Pipeline Products by Stage of Development
5 Deep Brain Stimulators Companies and Product Overview
5.1 Adaptive Neuromodulation GmbH Company Overview
5.1.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.2 Aleva Neurotherapeutics SA Company Overview
5.2.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boston Scientific Corp Company Overview
5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 Brainsway Ltd Company Overview
5.4.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cerene Biomedics, Inc. Company Overview
5.5.1 Cerene Biomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Cerevast Therapeutics Inc Company Overview
5.6.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Children's Hospital Boston Company Overview
5.7.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
5.8 Cleveland Medical Devices Inc Company Overview
5.8.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Clinatec Company Overview
5.9.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview
5.10 Deep Brain Innovations, LLC Company Overview
5.10.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Duke University Company Overview
5.11.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Functional Neuromodulation Inc. Company Overview
5.12.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Integer Holdings Corp Company Overview
5.13.1 Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 Iowa State University Company Overview
5.14.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
5.15 Massachusetts General Hospital Company Overview
5.15.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.16 Massachusetts Institute of Technology Company Overview
5.16.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.17 Mayo Clinic US Company Overview
5.17.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
5.18 Medtronic plc Company Overview
5.18.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.19 National Cheng-Kung University Hospital Company Overview
5.19.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.20 NeuroPro Technologies Inc Company Overview
5.20.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Neurosigma Inc Company Overview
5.21.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Newronika s.r.l. Company Overview
5.22.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
5.23 Nexeon MedSystems Inc Company Overview
5.23.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Rio Grande Neurosciences, Inc. Company Overview
5.24.1 Rio Grande Neurosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.26 St. Jude Medical LLC Company Overview
5.26.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.27 SUNY Downstate Medical Center Company Overview
5.27.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.28 University of California Los Angeles Company Overview
5.28.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.29 University of Central Florida Company Overview
5.29.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
5.30 University of Illinois Company Overview
5.30.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Michigan Company Overview
5.31.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.32 University of Milan Company Overview
5.32.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview
5.33 University of Oxford Company Overview
5.33.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
5.34 University of Rochester Company Overview
5.34.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
5.35 University of South Florida Company Overview
5.35.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
5.36 University of Utah Company Overview
5.36.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
5.37 Wedge Therapeutics Company Overview
5.37.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
6 Deep Brain Stimulators- Recent Developments
6.1 Aug 22, 2017: Brainsway Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017
6.2 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.3 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.4 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.5 Jun 12, 2017: Brainsway Announces Positive Final Results of its Deep-TMS Multicenter Study in Obsessive Compulsive Disorder (OCD) Patients
6.6 Jun 06, 2017: Boston Scientific Receives CE Mark for Vercise Gevia Deep Brain Stimulation System
6.7 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.8 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
6.9 Apr 03, 2017: Yaacov Michlin Leads Brainsway to its Next Growth Phase and Accelerates the Mental Health Industry
6.10 Apr 03, 2017: Sheppard Pratt Health System Appoints New Chief Operating Officer
6.11 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.12 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.13 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
6.14 Jan 11, 2017: Great Lakes NeuroTechnologies Awarded Deep Brain Stimulation Programming Patent
6.15 Jan 10, 2017: Brainsway Appoints Yaacov Michlin as CEO
6.16 Nov 28, 2016: Brainsway Reports Continued Financial Growth for Q3 of 2016
6.17 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.18 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.19 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
6.20 Nov 01, 2016: Sheppard Pratt Health System Appoints New Chief Financial Officer
6.21 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
6.22 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results
6.23 Oct 13, 2016: Baylor College of Medicine researcher and collaborators awarded grant through NIH BRAIN Initiative
6.24 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
6.25 Oct 07, 2016: Directional deep brain stimulation for movement disorders now being used
6.26 Oct 06, 2016: St. Jude Medical Announces U.S. Launch and First Implant of New Deep Brain Stimulation System and Directional Lead for Patients Suffering from Movement Disorders
6.27 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Deep Brain Stimulators - Pipeline Products by Stage of Development
Table 2: Deep Brain Stimulators - Pipeline Products by Territory
Table 3: Deep Brain Stimulators - Pipeline Products by Regulatory Path
Table 4: Deep Brain Stimulators - Pipeline Products by Estimated Approval Date
Table 5: Deep Brain Stimulators - Ongoing Clinical Trials
Table 6: Deep Brain Stimulators Companies - Pipeline Products by Stage of Development
Table 7: Deep Brain Stimulators - Pipeline Products by Stage of Development
Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 9: CR-Capable Implant - Product Status
Table 10: CR-Capable Implant - Product Description
Table 11: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
Table 12: directSTIM - Product Status
Table 13: directSTIM - Product Description
Table 14: spiderSTIM - Product Status
Table 15: spiderSTIM - Product Description
Table 16: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Cartesia Directional Lead - Product Status
Table 18: Cartesia Directional Lead - Product Description
Table 19: Enspire DBS Therapy System - Stroke - Product Status
Table 20: Enspire DBS Therapy System - Stroke - Product Description
Table 21: Enspire DBS Therapy System - Traumatic Brain Injury - Product Status
Table 22: Enspire DBS Therapy System - Traumatic Brain Injury - Product Description
Table 23: Vercise Deep Brain Stimulation System - Parkinson's Disease - Product Status
Table 24: Vercise Deep Brain Stimulation System - Parkinson's Disease - Product Description
Table 25: Vercise Primary Cell Deep Brain Stimulation System - Product Status
Table 26: Vercise Primary Cell Deep Brain Stimulation System - Product Description
Table 27: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 28: Vercise Deep Brain Stimulation System - Parkinson's Disease - Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation: CLOVER
Table 29: Vercise Deep Brain Stimulation System - Parkinson's Disease - Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation
Table 30: Vercise Deep Brain Stimulation System - Parkinson's Disease - Implantable Neurostimulator for the Treatment of Parkinson's Disease
Table 31: Vercise Deep Brain Stimulation System - Parkinson's Disease - Kombinierte Tiefe Hirnstimulation Des Nucleus Subthalamicus Und Nucleus Basalis Meynert Zur Behandlung Der Parkinson-Krankheit Mit Demenz
Table 32: Vercise Deep Brain Stimulation System - Parkinson's Disease - Registry of Deep Brain Stimulation with the VERCISE System: Vercise DBS Registry
Table 33: Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 34: H7-Deep-TMS System - Obsessive Compulsive Disorder - Product Status
Table 35: H7-Deep-TMS System - Obsessive Compulsive Disorder - Product Description
Table 36: Cerene Biomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Implantable Cooling Therapy Device - Product Status
Table 38: Implantable Cooling Therapy Device - Product Description
Table 39: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Neurosonx SR - Home Version - Product Status
Table 41: Neurosonx SR - Home Version - Product Description
Table 42: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
Table 43: rTMS H-Coil - Product Status
Table 44: rTMS H-Coil - Product Description
Table 45: Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: ParkinTune - Product Status
Table 47: ParkinTune - Product Description
Table 48: Clinatec Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Intracranial Deep Brain Stimulation Device - Product Status
Table 50: Intracranial Deep Brain Stimulation Device - Product Description
Table 51: Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 52: TOPS Device - Alzheimer's disease - Product Status
Table 53: TOPS Device - Alzheimer's disease - Product Description
Table 54: TOPS Device - Depression - Product Status
Table 55: TOPS Device - Depression - Product Description
Table 56: TOPS Device - Epilepsy - Product Status
Table 57: TOPS Device - Epilepsy - Product Description
Table 58: TOPS Device - Obesity - Product Status
Table 59: TOPS Device - Obesity - Product Description
Table 60: TOPS Device - Obsessive-Compulsive Disorder - Product Status
Table 61: TOPS Device - Obsessive-Compulsive Disorder - Product Description
Table 62: TOPS Device - Parkinson's disease - Product Status
Table 63: TOPS Device - Parkinson's disease - Product Description
Table 64: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 65: DBS Electrode - Product Status
Table 66: DBS Electrode - Product Description
Table 67: Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Deep Brain Stimulation - Mild Alzheimer's Disease - Product Status
Table 69: Deep Brain Stimulation - Mild Alzheimer's Disease - Product Description
Table 70: Functional Neuromodulation Inc. - Ongoing Clinical Trials Overview
Table 71: Deep Brain Stimulation - Mild Alzheimer's Disease - A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients with Mild Probable Alzheimer's Disease
Table 72: Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Disposable Surgical Electrode - Product Status
Table 74: Disposable Surgical Electrode - Product Description
Table 75: Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Triple Halo Coil - Product Status
Table 77: Triple Halo Coil - Product Description
Table 78: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Deep Brain Stimulation Device - Product Status
Table 80: Deep Brain Stimulation Device - Product Description
Table 81: Deep Brain Stimulation System - Product Status
Table 82: Deep Brain Stimulation System - Product Description
Table 83: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Implantable Micro - Cannula Device - Product Status
Table 85: Implantable Micro - Cannula Device - Product Description
Table 86: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Sensor System - DBS - Product Status
Table 88: Sensor System - DBS - Product Description
Table 89: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Activa SC Neurostimulator - Epilepsy - Product Status
Table 91: Activa SC Neurostimulator - Epilepsy - Product Description
Table 92: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Product Status
Table 93: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Product Description
Table 94: Reclaim Deep Brain Stimulation System - Depression - Product Status
Table 95: Reclaim Deep Brain Stimulation System - Depression - Product Description
Table 96: Sapiens DBS Field Steering System - Product Status
Table 97: Sapiens DBS Field Steering System - Product Description
Table 98: Medtronic plc - Ongoing Clinical Trials Overview
Table 99: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Medtronic Registry for Epilepsy: MORE
Table 100: National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 101: Responsive Epilepsy Control System-On-Chip - Product Status
Table 102: Responsive Epilepsy Control System-On-Chip - Product Description
Table 103: NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 104: Deep Brain Stimulation - Product Status
Table 105: Deep Brain Stimulation - Product Description
Table 106: Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 107: Deep Brain Stimulation System - Cachexia - Product Status
Table 108: Deep Brain Stimulation System - Cachexia - Product Description
Table 109: Deep Brain Stimulation System - Obesity - Product Status
Table 110: Deep Brain Stimulation System - Obesity - Product Description
Table 111: Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Implantable Deep Brain Stimulation Device - Product Status
Table 113: Implantable Deep Brain Stimulation Device - Product Description
Table 114: Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Synapse - Product Status
Table 116: Synapse - Product Description
Table 117: Rio Grande Neurosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 118: DSF-rTMS - Product Status
Table 119: DSF-rTMS - Product Description
Table 120: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 121: Implantable Electrode - Epilepsy Surgery - Product Status
Table 122: Implantable Electrode - Epilepsy Surgery - Product Description
Table 123: Indigenous Deep Brain Stimulation Device - Product Status
Table 124: Indigenous Deep Brain Stimulation Device - Product Description
Table 125: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 126: Libra Deep Brain Stimulation System - Depression - Product Status
Table 127: Libra Deep Brain Stimulation System - Depression - Product Description
Table 128: Next Generation Implantable DBS System - Primary Cell - Product Status
Table 129: Next Generation Implantable DBS System - Primary Cell - Product Description
Table 130: St. Jude Medical LLC - Ongoing Clinical Trials Overview
Table 131: Libra Deep Brain Stimulation System - Depression - A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression
Table 132: Libra Deep Brain Stimulation System - Depression - Deep Brain Stimulation for Treatment-Resistant Depression
Table 133: SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 134: Low-Frequency Sine Wave Neurostimulation Therapy Device - Product Status
Table 135: Low-Frequency Sine Wave Neurostimulation Therapy Device - Product Description
Table 136: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
Table 137: Implantable Ultrasound Neuromodulation Device - Product Status
Table 138: Implantable Ultrasound Neuromodulation Device - Product Description
Table 139: Wireless Deep Brain Stimulating System - Product Status
Table 140: Wireless Deep Brain Stimulating System - Product Description
Table 141: University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview
Table 142: Deep Brain Stimulation System - Product Status
Table 143: Deep Brain Stimulation System - Product Description
Table 144: University of Illinois Pipeline Products & Ongoing Clinical Trials Overview
Table 145: Wireless Deep Brain Stimulation System - Essential Tremor - Product Status
Table 146: Wireless Deep Brain Stimulation System - Essential Tremor - Product Description
Table 147: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
Table 148: Deep Brain Stimulation System - Product Status
Table 149: Deep Brain Stimulation System - Product Description
Table 150: University of Milan Pipeline Products & Ongoing Clinical Trials Overview
Table 151: Implantable Brain Pacemaker - Product Status
Table 152: Implantable Brain Pacemaker - Product Description
Table 153: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
Table 154: Adaptive Deep Brain Stimulation System - Product Status
Table 155: Adaptive Deep Brain Stimulation System - Product Description
Table 156: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
Table 157: Deep Brain Magnetic Stimulator - Product Status
Table 158: Deep Brain Magnetic Stimulator - Product Description
Table 159: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
Table 160: Deep Brain Stimulator - Product Status
Table 161: Deep Brain Stimulator - Product Description
Table 162: University of South Florida - Ongoing Clinical Trials Overview
Table 163: Deep Brain Stimulator - Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi) Deep Brain Stimulation (DBS) in Patients with Primary Dystonia
Table 164: University of Utah Pipeline Products & Ongoing Clinical Trials Overview
Table 165: DBS10k - Product Status
Table 166: DBS10k - Product Description
Table 167: Neural Recording Array - Product Status
Table 168: Neural Recording Array - Product Description
Table 169: Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
Table 170: SONS System - Product Status
Table 171: SONS System - Product Description
Table 172: Glossary

List of Figures
Figure 1: Deep Brain Stimulators - Pipeline Products by Stage of Development
Figure 2: Deep Brain Stimulators - Pipeline Products by Territory
Figure 3: Deep Brain Stimulators - Pipeline Products by Regulatory Path
Figure 4: Deep Brain Stimulators - Pipeline Products by Estimated Approval Date
Figure 5: Deep Brain Stimulators - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Adaptive Neuromodulation GmbH
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corp
  • Brainsway Ltd
  • Cerene Biomedics, Inc.
  • Cerevast Therapeutics Inc
  • Children's Hospital Boston
  • Cleveland Medical Devices Inc
  • Clinatec
  • Deep Brain Innovations, LLC
  • Duke University
  • Functional Neuromodulation Inc.
  • Integer Holdings Corp
  • Iowa State University
  • Massachusetts General Hospital
  • Massachusetts Institute of Technology
  • Mayo Clinic US
  • Medtronic plc
  • National Cheng-Kung University Hospital
  • NeuroPro Technologies Inc
  • Neurosigma Inc
  • Newronika s.r.l.
  • Nexeon MedSystems Inc
  • Rio Grande Neurosciences, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • St. Jude Medical LLC
  • SUNY Downstate Medical Center
  • University of California Los Angeles
  • University of Central Florida
  • University of Illinois
  • University of Michigan
  • University of Milan
  • University of Oxford
  • University of Rochester
  • University of South Florida
  • University of Utah
  • Wedge Therapeutics
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll